By CHAD BRAY
The British drug maker plans to acquire treatments at various stages of research in a deal with Bristol-Myers Squibb of New York that could be worth $1.46 billion.
Published: December 19, 2015 at 12:00AM
from NYT Business Day http://ift.tt/1QR5uIc
from WordPress http://ift.tt/1JgjncF
via Hadi Aboukhater
No comments:
Post a Comment